The North America Home Healthcare Market was valued at USD 47,600 Million in 2025 and is anticipated to reach USD 126,400 Million by 2035, growing at a CAGR of 9.4% from 2024 to 2035. Increased aging population, technological advancements, and increased prevalence of chronic diseases are boosting the demand for home-based care models. The market encompasses a wide array of services, equipment, and software targeted at patient-centered care outside hospital settings.
The economic impact of tariffs on "North America Home Healthcare Market".
Market Growth Drivers
Growing Aging Population: The rapidly increasing aging population in the United States and Canada is one of the primary growth drivers of the North America Home Healthcare Market. According to Amedisys, Inc., the U.S. Census Bureau estimates that by 2030, one in five Americans will be aged 65 or older. This segment of the population is most in need of home healthcare due to chronic conditions and post-surgical care, fueling demand for both personal and professional home healthcare services.
Technological Advancements in Remote Monitoring: The rise of advanced telehealth and remote monitoring technologies has significantly enhanced the efficacy and reach of home healthcare services. Companies like LHC Group, Inc. utilize remote patient monitoring, electronic health records, and IoT-based devices for continuous patient assessment, reducing complications, and driving the adoption of home-based care.
Market Trends
Increased Adoption of Telehealth Solutions: The integration of telehealth technology in home healthcare is a major trend, especially escalated by the COVID-19 pandemic. Companies like Teladoc Health are offering virtual visits and remote health management, making healthcare more accessible for patients with mobility issues or living in remote regions. The adoption rate of digital health solutions in home care services continues to rise, streamlining care coordination and patient engagement.
Expansion of Home Infusion Therapy: There is growing demand for home infusion therapies for chronic conditions such as cancer, diabetes, and autoimmune disorders. Baxter International and Option Care Health have expanded their home infusion services portfolios, emphasizing patient safety and convenience, while also reducing hospitalization and overall medical costs.
Market Opportunity
Integration of Artificial Intelligence (AI) and Data Analytics: The implementation of AI-powered decision support, predictive analytics, and automated care scheduling offers substantial opportunities for enhancing patient outcomes and optimizing resource allocation. Companies like Philips are developing AI-driven platforms tailored for home care settings.
Strategic Partnerships and Acquisitions: Increasing partnerships between home healthcare providers and technology companies present lucrative market opportunities. For instance, recent collaborations between Humana Inc. and Heal enhance remote care capabilities and comprehensive in-home services.
North America Home Healthcare Market Revenue (USD Million), 2020-2035
The revenue graph for the North America Home Healthcare Market from 2020 to 2035 indicates a strong upward trajectory. In 2020, the market was valued at USD 28,700 Million and demonstrated steady growth over the years, reaching USD 47,600 Million by 2025. The momentum continues, with the market projected to touch USD 126,400 Million in 2035. The CAGR of 9.4% reflects robust investments in health technologies, expanded service portfolios, and the broader shift towards aging in place. This growth denotes enhanced penetration of home healthcare across urban and rural settings, supported by public and private payers.
North America Home Healthcare Market by Region Share (%), 2025
In 2025, the United States dominates the North America Home Healthcare Market with 68% share, driven by advanced infrastructure, higher healthcare spending, and favorable reimbursement policies. Canada holds 22% share, reflecting strong support for publicly funded home care initiatives. Mexico represents 5% of the market, gradually embracing home-based services. The rest of North America (including Caribbean countries) accounts for 3%, with growing interest in innovative care solutions. This distribution demonstrates concentrated market activity in the U.S., with Canada emerging as a promising market for expansion.
Recent Developments in the North America Home Healthcare Market
In January 2024, Amedisys, Inc. announced a strategic partnership with Medtronic to integrate advanced cardiac monitoring solutions into Amedisys’s home health offerings. The collaboration aims to deploy remote monitoring for heart failure and chronic cardiac patients, reducing readmissions and improving patient outcomes.
In March 2024, Humana Inc. expanded its in-home care program by acquiring a majority stake in a leading telehealth provider. This move aims to deliver a seamless integration of in-person and digital care, supporting chronic disease management and patient engagement through AI-powered health platforms.
In April 2024, LHC Group, Inc. launched a new digital platform that enables real-time coordination between home healthcare teams, patients, and their families. This platform uses AI-driven scheduling, remote patient monitoring, and secure messaging features, enhancing care delivery and patient satisfaction across multiple states.
By Type (Equipment, Services, Software), By Application (Cardiac Care, Respiratory Care, Mobility Care, Diabetes, Wound Care, Others), By Distribution Channels (Retail Pharmacies, Online Pharmacies, Direct Tenders, Homecare Agencies, Hospitals, Others), By Technology (Telehealth, Remote Monitoring, mHealth, Connected Devices, Cloud-based Solutions, Others), By Organization Size (Small, Medium, Large)
Press Releases